What are the possible causes of bradycardia in a patient with cancer?

Causes of Bradycardia in Cancer Patients

Bradycardia in cancer patients results from three main mechanisms: direct cardiotoxicity from chemotherapeutic agents, tumor infiltration of cardiac conduction tissue, and tumor-related compression of the vagus nerve.

Chemotherapy-Induced Bradycardia

The most common cause is direct cardiotoxic effects from cancer therapeutics. According to the 2016 ESC Position Paper, multiple chemotherapeutic agents are associated with bradycardia 1:

High-Risk Agents:

• Arsenic trioxide (highest risk)
• Taxanes (paclitaxel)
• Anthracyclines (doxorubicin, epirubicin)
• Platinum agents (cisplatin)
• Proteasome inhibitors (bortezomib)
• Alkylating agents (cyclophosphamide, ifosfamide)
• Antimetabolites (5-fluorouracil, capecitabine, methotrexate)
• Immunomodulators (thalidomide, IL-2, rituximab)
• Mitoxantrone

Importantly, many of these same agents also cause AV block, including anthracyclines, arsenic trioxide, bortezomib, cyclophosphamide, 5-FU, mitoxantrone, rituximab, taxanes, and thalidomide 1.

The majority of chemotherapy-induced bradycardia is asymptomatic 2. When symptoms occur, they include fatigue, dizziness, pre-syncope, or syncope.

Direct Tumor Effects

Infiltration of the AV node by malignancy represents a critical but less common mechanism 2:

• Lymphoma can directly infiltrate cardiac conduction tissue
• Amyloidosis (particularly in multiple myeloma) causes infiltrative conduction disease
• 10% of catecholamine-secreting tumors (pheochromocytoma, paraganglioma) paradoxically cause bradycardia and heart block 2
• Vagal paragangliomas can cause significant heart block through direct neural involvement 2

Tumor Compression

Mechanical compression of the vagus nerve by tumor mass causes reflex bradycardia 2:

• Neck masses involving vagus nerves
• Mediastinal lymphadenopathy (particularly calcified paratracheal nodes near the vagus nerve) 3
• This mechanism is potentially reversible with surgical resection of compressing lymph nodes 3

Additional Contributing Factors

Electrolyte disturbances commonly occur in cancer patients due to:

• Nausea, vomiting, and diarrhea from chemotherapy
• Decreased oral intake
• Metabolic derangements from advanced disease 2

Concomitant medications that prolong QT interval or affect cardiac conduction:

• Anti-emetics
• Antibiotics
• Psychotropic medications
• Cardiac medications 1

Procedural interventions: Percutaneous ethanol injection for hepatocellular carcinoma can cause sinus bradycardia and heart block 2.

Clinical Significance

Arrhythmias are present at baseline in 16-36% of treated cancer patients 1. While most bradycardia is asymptomatic, it merits attention because:

1. It represents a risk factor for QT prolongation - several agents causing bradycardia also prolong QT interval (arsenic trioxide, anthracyclines, taxanes) 4
2. Cancer is an age-related disease, and bradycardia incidence increases with aging 4
3. Some agents require continuation despite bradycardia - thalidomide may necessitate permanent pacemaker placement to allow therapy continuation 2

Management Approach

When bradycardia is identified, systematically evaluate:

1. Review all medications for offending agents (chemotherapy and concomitant drugs)
2. Assess for tumor infiltration via imaging (echocardiography, cardiac MRI, CT for mediastinal masses)
3. Check electrolytes and correct abnormalities
4. Determine symptom severity - most patients are asymptomatic and require only monitoring 2

For symptomatic bradycardia:

• Junctional escape rhythm: Pacemaker only if symptomatic
• Ventricular escape rhythm: Unstable - requires pacemaker implantation 2
• If clear offending drug identified: Consider alternative therapy
• If no substitution available: Close monitoring during chemotherapy; temporary pacemaker or isoproterenol infusion may bridge therapy 2
• For thalidomide without alternatives: Permanent pacemaker may be necessary 2

In patients with active infection, temporary pacemaker placement is preferred until infection resolves 2.

Critical caveat: In some cases, bradycardia resolves with treatment of the primary malignancy, particularly when caused by tumor infiltration or compression 2, 3. Surgical resection of compressing mediastinal lymph nodes can immediately resolve severe bradycardia 3.